Topics
Glioblastoma | Treatment | Chemotherapy | Lomustine
Home > Publications > Topics > Glioblastoma > Treatment > Chemotherapy > Lomustine
Preusser
M, Kazda T, Le Rhun E, Sahm F, Smits M, Gempt J, Koekkoek JA,
Monti AF, Csanadi M, Pitter JG, Bulbek H, Fournier B, Quoilin C,
Gorlia T, Weller M, Minniti G; European Organisation for Research,
Treatment of Cancer (EORTC) Brain Tumor Group.
Lomustine
with or without reirradiation for first progression of
glioblastoma, LEGATO, EORTC-2227-BTG: study protocol for a
randomized phase III study.
Trials.
2024 Jun 7;25(1):366. doi:
10.1186/s13063-024-08213-7. PMID:
38849943. Interventional study protocol. ˍ
Mergen E, Landrock S, Chizzali B.
Tumor
Treating Fields (TTFields) Therapy and Lomustine Chemotherapy for
the Treatment of Unresectable Progressive Glioblastoma.
Case
Rep Oncol. 2024 Sep 23;17(1):1056-1062. doi:
10.1159/000540669. PMID:
39474554. Case report. ˍ
*Zeyen T, Treiber A, Schneider M,
Potthoff AL, Schaub C, Roever L, Layer JP, Gkika E, Vatter H,
Paech D, Radbruch A, Schaefer N, Herrlinger U, Weller J.
Second-line
temozolomide in first recurrent MGMT-methylated glioblastoma after
lomustine/temozolomide: Efficacy and safety.
Neurooncol
Adv. 2025 Apr
28;7(1):vdaf084. doi:
10.1093/noajnl/vdaf084. PMID:
40575419. Observational study. ˍ
Chen J, Oberheim Bush NA, Grabowsky JA, Kline C, Kroetz DL, Taylor
JW, Villanueva-Meyer J, Molinaro AM, de Groot JF, Butowski NA,
Tedesco M, Rabbitt J, Phillips JJ, Hervey-Jumper S, Aghi MK,
Berger MS, Chang EF, Chang SM, Solomon DA, Clarke JL.
A
genomically-tailored multi-agent precision medicine clinical trial
for adults with recurrent glioblastoma.
Clin
Cancer Res. 2026 Feb 6. doi:
10.1158/1078-0432.CCR-25-4080. PMID:
41649856. Interventional study.
ˍ